Profile
Paula K.
Cobb is currently Director at NightstaRx Ltd. and Chief Operating Officer at Manifold Biotechnologies, Inc. Former positions include Independent Non-Executive Director at Nightstar Therapeutics Ltd. from 2018 to 2019, Independent Director at Prothena Corp.
Plc from 2019 to 2025, Senior Vice President-Rare Disease Group at Biogen, Inc. from 2015 to 2016, Chief Operating Officer at Decibel Therapeutics, Inc. in 2019, and Chief Business Officer at Affinia Therapeutics, Inc. from 2020 to 2023.
Education includes undergraduate studies at Amherst College and an MBA from Harvard Business School.
Paula Cobb active positions
| Companies | Position | Start |
|---|---|---|
NightstaRx Ltd.
NightstaRx Ltd. Medical/Nursing ServicesHealth Services development of therapies for retinal dystrophies | Director/Board Member | - |
Manifold Biotechnologies, Inc.
Manifold Biotechnologies, Inc. BiotechnologyHealth Technology Operates as biotechnology company | Chief Operating Officer | 2025-11-30 |
Former positions of Paula Cobb
| Companies | Position | End |
|---|---|---|
| PROTHENA CORPORATION PLC | Director/Board Member | 2025-12-30 |
Affinia Therapeutics, Inc.
Affinia Therapeutics, Inc. BiotechnologyHealth Technology Develops adeno-associated virus gene therapies | Corporate Officer/Principal | 2022-12-31 |
| DECIBEL THERAPEUTICS, INC. | Chief Operating Officer | 2019-11-30 |
| NIGHTSTAR THERAPEUTICS PLC | Director/Board Member | 2019-06-06 |
| BIOGEN INC. | Corporate Officer/Principal | 2015-12-31 |
Training of Paula Cobb
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 9 |
|---|---|
Biogen, Inc.
Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Amherst College
Amherst College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Prothena Corp. Plc
Prothena Corp. Plc BiotechnologyHealth Technology Focuses on the discovery and development of novel antibodies | Health Technology |
Harvard Business School
Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NightstaRx Ltd.
NightstaRx Ltd. Medical/Nursing ServicesHealth Services development of therapies for retinal dystrophies | Health Services |
Decibel Therapeutics, Inc.
Decibel Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops medicines for hearing and balance disorders | Health Technology |
Nightstar Therapeutics Ltd.
Nightstar Therapeutics Ltd. BiotechnologyHealth Technology Operates as a gene therapy company that develops novel treatments for patients suffering from inherited retinal diseases | Health Technology |
Affinia Therapeutics, Inc.
Affinia Therapeutics, Inc. BiotechnologyHealth Technology Develops adeno-associated virus gene therapies | Health Technology |
Manifold Biotechnologies, Inc.
Manifold Biotechnologies, Inc. BiotechnologyHealth Technology Operates as biotechnology company | Health Technology |
- Stock Market
- Insiders
- Paula Cobb
















